Production (Stage)
Cue Biopharma, Inc.
CUE
$0.59
-$0.012-1.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.05M | 23.39M | 32.42M | 30.03M | 41.03M |
| Total Receivables | -- | 945.00K | 3.15M | 1.85M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.88M | 805.00K | 1.68M | 2.02M | 2.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.93M | 25.14M | 37.26M | 33.90M | 44.67M |
|
|
|||||
| Total Current Assets | 15.93M | 25.14M | 37.26M | 33.90M | 44.67M |
| Net Property, Plant & Equipment | 4.11M | 4.84M | 4.60M | 5.48M | 6.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.21M | 2.21M | 2.95M | 2.95M | 2.96M |
| Total Assets | 22.25M | 32.19M | 44.81M | 42.33M | 53.95M |
|
|
|||||
| Total Accounts Payable | 3.78M | 2.82M | 6.47M | 3.91M | 3.92M |
| Total Accrued Expenses | 4.23M | 2.91M | 3.20M | 4.56M | 5.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.95M | 7.87M | 6.86M | 7.02M | 7.17M |
| Total Finance Division Other Current Liabilities | 535.00K | 85.00K | 259.00K | 976.00K | 1.79M |
| Total Other Current Liabilities | 535.00K | 85.00K | 259.00K | 976.00K | 1.79M |
| Total Current Liabilities | 15.50M | 13.69M | 16.79M | 16.46M | 18.09M |
|
|
|||||
| Total Current Liabilities | 15.50M | 13.69M | 16.79M | 16.46M | 18.09M |
| Long-Term Debt | -- | -- | 1.33M | 2.29M | 3.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 176.00K | 1.00M | 1.33M | 1.96M | 2.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.67M | 14.69M | 19.44M | 20.71M | 23.91M |
|
|
|||||
| Common Stock & APIC | 360.70M | 359.36M | 357.73M | 345.33M | 343.58M |
| Retained Earnings | -354.12M | -341.86M | -332.37M | -323.71M | -313.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.58M | 17.50M | 25.37M | 21.62M | 30.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.58M | 17.50M | 25.37M | 21.62M | 30.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.58M | 17.50M | 25.37M | 21.62M | 30.04M |
|
|
|||||